CClinicalTrials.gg
RecruitingNCT06277102Updated Feb 26, 2024

Effects of Music on Acute Postoperative Pain Intensity and Mobility After Fragility Hip Fracture

An interventional study of music listening in Hip Fractures, sponsored by Hospital Authority, Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-02-26.

Sponsored by Hospital Authority, Hong Kong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Music has been proven to be beneficial in postoperative care by reducing pain. The effects of music listening to reduce pain postoperatively are well studied among cases undergoing elective orthopaedic surgery. No study has been conducted focusing on pain control among cases with fragility hip fractures in an acute ward setting with non-schedule non-elective orthopaedic operation.

In Queen Elizabeth Hospital a standardized analgesic protocol is used for all fragility hip fracture cases unless contraindicated, a suboptimal post-operative pain control is not uncommonly seen. Stepping up analgesics is usually a concern in the elderly with a higher rate of side effects, a safe and simple non-pharmacological intervention for pain control is therefore needed.

The aim of this study is to study the effectiveness of incorporating music on pain intensity and mobility with the standard postoperative rehabilitation care of fragility hip fracture in Queen Elizabeth Hospital.

02

Conditions studied

  • Hip Fractures

Keywords

  • pain control
  • music
  • fragility hip fracture
03

In context

Pain, Postoperative

5,089 studies on the registry are indexed under Pain, Postoperative; 1,137 are open to participants now.

This study's planned enrollment of 60 is below the median of 75 across 4,341 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Hospital Authority, Hong Kong is the lead sponsor of 73 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Emergency admitted to QEH/G9 due to fragility hip fracture (#NOF or # TOF) within the study period
  2. Plan for surgical intervention
  3. Able to provide written informed consent
  4. Able to communicate in Cantonese/ Putonghua/ English

Exclusion criteria

Exclusion Criteria:

  1. History of dementia
  2. Acute delirium upon admission
  3. Disorientated to time, person or place
  4. Concurrent fracture at other sites
  5. Utilization of other analgesics on top of pain protocol
  6. Appreciable deficits in hearing or vision
  7. Hemodynamically unstable
  8. Plan for neurolysis/ nerve block as definite treatment or opt for conservative treatment
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Music

    Music listening at postoperative day 1 and 2, 1 session per day, 20 minutes per session.

    Other: music listening

  • No intervention
    Control

    Standard of care

Interventions

  • Othermusic listening

    Music listening at postoperative day 1 and 2, 1 session per day, 20 minutes per session.

06

What researchers measure

Primary outcomes

  1. Pain intensity measured by 11-point pain intensity numerical rating scale after music listening in postoperative Day 1 - 2 among subjects with fragility hip fracture

    Time frame: postoperative day 1 and 2

Secondary outcomes

  1. Modified functional ambulatory classification (MFAC) in postoperative Day 3 among subjects with fragility hip fracture

    Time frame: postoperative day 3

  2. New mobility score (NMS) in postoperative Day 3 among subjects with fragility hip fracture

    Time frame: postoperative day 3

07

Study locations

1 of 1 sites recruiting
  • Ward G9, Queen Elizabeth Hospital
    Hong Kong, Hong Kong
    • Kwan Yiu Jeffrey Lau · Contact · lky194a@ha.org.hk · 62017014
    • Kwan Yiu Jeffrey Lau · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06277102
Lead sponsor
Hospital Authority, Hong Kong
Responsible party
Lau Kwan Yiu Jeffrey (Advanced Practice Nurse, Hospital Authority, Hong Kong) — Principal investigator
First posted
Feb 26, 2024
Start date
Jan 26, 2024
Primary completion
Jun 1, 2024 (estimated)
Completion
Jun 1, 2024 (estimated)
Last update
Feb 26, 2024

Study contacts

Kwan Yiu Jeffrey Lau
Contact
lky194a@ha.org.hk
62017014

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion